Dr. Hani Abdullah Alhadrami

Dr. Hani A. Alhadrami received his BSc in Medical Technology and his master and PhD in Medical Biotechnology from the University of Aberdeen, United Kingdom. He was a visiting assisting professor at Harvard Medical School and Harvard-MIT Division of Health Sciences and Technology. His research contributions have been focused on the development of DNA aptamer based microfluidic electrochemical biosensor for continuous monitoring of heart-on-a-chip. Currently, he is working as Associate Professor & Consultant of Molecular Diagnostics & Medical Biotechnology at King Abdulaziz University Hospital and King Fahad Medical Research Center, King Abdulaziz University. He is a research fellow at the Center of Excellence in Genomic Medicine Research and the Special Infectious Agent Unit Biosafety Level 3. He is also leading the research group of Nanobiotechnology for Medical Applications, King Fahad Medical Research Center, King Abdulaziz University. Dr. Alhadrami has enough experience in the development, characterization, and optimization of several genetically modified bioluminescence-based biosensors for mutagenicity, carcinogenicity and toxicity assessments. His area of expertise involves medical applications of Genetically Modified Biosensors, Microfluidics, Lab-on-a-chip, DNA aptamer, drug discovery and designing biosensors for detection and diagnosis of emerging viruses. Dr. Alhadrami has granted a patent Developed and invented a diagnostic assay for the detection of CVOID-19 and patented it in the United States Patent and Trademark Office under filling number 17108263